| 49.51 Data as of May 17 |  +0.88 / +1.81%Today’s Change | 36.73 Today|||52-Week Range 49.86 | +17.74% Year-to-Date |
| Pipeline Progress at Gilead - Analyst Blog May 16 / Zacks.com | NPS Pharma Incurs Narrower 1Q Loss - Analyst Blog May 14 / Zacks.com |
| Cempra/Toyama Ink Deal - Analyst Blog May 15 / Zacks.com | Setback for Endo Health on Opana ER - Analyst Blog May 13 / Zacks.com |
| Synergy Pharma Posts Wider Loss - Analyst Blog May 15 / Zacks.com | Earnings Beat at Warner Chilcott - Analyst Blog May 13 / Zacks.com |
| Wider-Than-Expected Loss at Athersys - Analyst Blog May 15 / Zacks.com | Narrower-than-Expected Loss at MannKind - Analyst Blog May 13 / Zacks.com |
| Celgene Attains 52-Week High - Analyst Blog May 14 / Zacks.com | Wider-than-Expected Loss at Optimer - Analyst Blog May 10 / Zacks.com |
| Previous close | 48.63 |
| Today’s open | 48.71 |
| Day’s range | 48.35 - 49.62 |
| Volume | 976,865 |
| Average volume (3 months) | 765,284 |
| Market cap | $3.2B |
| Dividend yield | -- |
| Earnings growth (last year) | +303.85% |
| Earnings growth (this year) | -40.12% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +22.86% |
| P/E ratio | 28.6 |
| Price/Sales | 2.89 |
| Price/Book | 3.23 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARIAARIAD Pharmaceutical... | +0.20 | +1.21% |
| PRXLPAREXEL Internationa... | -0.12 | -0.26% |
| ISISIsis Pharmaceuticals... | +0.50 | +2.48% |
| CRLCharles River Labora... | -0.12 | -0.27% |
| Next reporting date | July 18, 2013 |
| EPS forecast (this quarter) | $0.39 |
| Annual revenue (last year) | $926.4M |
| Annual profit (last year) | $154.1M |
| Net profit margin | 16.63% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Michael W. Bonney |
President & Chief Operating Officer Robert J. Perez, Jr., MBA |
Corporate headquarters Lexington, Massachusetts |
.
